ID

24054

Beschrijving

Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00469092

Link

https://clinicaltrials.gov/show/NCT00469092

Trefwoorden

  1. 24-07-17 24-07-17 -
Geüploaded op

24 juli 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Diabetes NCT00469092

Eligibility Diabetes NCT00469092

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00469092
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes
Beschrijving

Diabetes Mellitus, Non-Insulin-Dependent

Datatype

boolean

Alias
UMLS CUI [1]
C0011860
treatment with oads (oral anti-diabetic drugs) for more than 6 months
Beschrijving

Antidiabetics Oral

Datatype

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
ongoing stable treatment with metformin for at least 2 months
Beschrijving

Metformin

Datatype

boolean

Alias
UMLS CUI [1]
C0025598
ongoing stable treatment with minimum half maximal dose of any insulin secretagogue for at least 2 months
Beschrijving

Pills Insulin Releasing | Dose Stable

Datatype

boolean

Alias
UMLS CUI [1,1]
C0994475
UMLS CUI [1,2]
C0021641
UMLS CUI [1,3]
C1283071
UMLS CUI [2,1]
C0178602
UMLS CUI [2,2]
C0205360
insulin naive
Beschrijving

Insulin naive

Datatype

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C0919936
hba1c (glycosylated haemoglobin a1c) between 7.0% and 11.0% (inclusive of both values)
Beschrijving

Glycosylated hemoglobin A

Datatype

boolean

Alias
UMLS CUI [1]
C0019018
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
metformin contraindication according to local practice
Beschrijving

Medical contraindication Metformin

Datatype

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0025598
tzd (thiazolidinedione) treatment for the last 5 months before trial start
Beschrijving

Thiazolidinediones

Datatype

boolean

Alias
UMLS CUI [1]
C1257987
systemic treatment with any corticosteroid 3 months before trial start
Beschrijving

Systemic Corticosteroid Therapy

Datatype

boolean

Alias
UMLS CUI [1]
C4053960
any disease or condition which according to the investigator would interfere with the trial
Beschrijving

Disease Interferes with Clinical Trial | Condition Interferes with Clinical Trial

Datatype

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0008976
UMLS CUI [2,1]
C0348080
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0008976

Similar models

Eligibility Diabetes NCT00469092

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00469092
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Antidiabetics Oral
Item
treatment with oads (oral anti-diabetic drugs) for more than 6 months
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
Metformin
Item
ongoing stable treatment with metformin for at least 2 months
boolean
C0025598 (UMLS CUI [1])
Pills Insulin Releasing | Dose Stable
Item
ongoing stable treatment with minimum half maximal dose of any insulin secretagogue for at least 2 months
boolean
C0994475 (UMLS CUI [1,1])
C0021641 (UMLS CUI [1,2])
C1283071 (UMLS CUI [1,3])
C0178602 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
Insulin naive
Item
insulin naive
boolean
C0021641 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
Glycosylated hemoglobin A
Item
hba1c (glycosylated haemoglobin a1c) between 7.0% and 11.0% (inclusive of both values)
boolean
C0019018 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Medical contraindication Metformin
Item
metformin contraindication according to local practice
boolean
C1301624 (UMLS CUI [1,1])
C0025598 (UMLS CUI [1,2])
Thiazolidinediones
Item
tzd (thiazolidinedione) treatment for the last 5 months before trial start
boolean
C1257987 (UMLS CUI [1])
Systemic Corticosteroid Therapy
Item
systemic treatment with any corticosteroid 3 months before trial start
boolean
C4053960 (UMLS CUI [1])
Disease Interferes with Clinical Trial | Condition Interferes with Clinical Trial
Item
any disease or condition which according to the investigator would interfere with the trial
boolean
C0012634 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial